Hans Hull - 14 Jul 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Business Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
14 Jul 2023
Transactions value $
$0
Form type
4
Filing time
18 Jul 2023, 19:19:41 UTC
Previous filing
03 Apr 2023
Next filing
19 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Award $0 +35,156 +17% $0 237,120 14 Jul 2023 Direct F1
holding PLRX Common Stock 3,821 14 Jul 2023 See footnote F2
holding PLRX Common Stock 13,985 14 Jul 2023 See footnote F3
holding PLRX Common Stock 13,985 14 Jul 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 28, 2022, the Reporting Person was granted 70,312 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On July 14, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 35,156 shares.
F2 The shares are held by The Sloger Hull Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.
F3 The shares are held by a trust for the Reporting Person's minor child ("Child A Trust"). The Reporting Person and his spouse serve as trustees for Child A Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 The shares are held by a trust for the Reporting Person's minor child ("Child B Trust"). The Reporting Person and his spouse serve as trustees for Child B Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.